(Q61862445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

4

J Machann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

9

F Schick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

10

A Fritsche

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

F Machicao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Konstantinos Kantartzis

2

object named as

K Kantartzis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

11

H-U Häring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

A Peter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

S Wagner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

S Templin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

I Königsrainer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Königsrainer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

9 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

774-782

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2011.154

10 February 2020

exact match

0 references

cites work

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Causes and metabolic consequences of Fatty liver

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Fatty liver: a novel component of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

The impact of liver fat vs visceral fat in determining categories of prediabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Benefits of lifestyle modification in NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

ApoC-III gene polymorphisms and risk of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Genetic susceptibility to hepatic steatosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Plasma fetuin-A levels and the risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2011.154

7 January 2021

Identifiers

DOI

10.1038/IJO.2011.154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21829161%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 February 2020

0 references

1 reference